ClinicalTrials.Veeva

Menu

Analysis of Biological Progression and Regression of HELLP Syndrome in Time

C

CHU Mohammed VI Marrakech

Status

Enrolling

Conditions

Preeclampsia
HELLP Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT06758960
67/2024

Details and patient eligibility

About

Prospective observational study about progression and regression of biological parameters of HELLP syndrome

Full description

Data collection included a comprehensive review of pathological histories, identification of complications based on clinical presentation, daily monitoring of biological parameters, documentation of transfusion events, recording of corticosteroid administration according to gestational age, and detailed reporting of extraction and analgesia techniques.

Enrollment

70 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women who are admitted to the maternal ICU for a biological HELLP syndrome

Exclusion criteria

  • Patients whose biological presentation was attributable to other conditions, such as microangiopathies or leukemia.
  • Patients who benefited from plasma exchange therapy

Trial design

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Meryem Essafti, Assistant Professor; Nizar Amllah, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems